Literature DB >> 24345847

Structure-property relationships based on Hammett constants in cyclometalated iridium(III) complexes: their application to the design of a fluorine-free FIrPic-like emitter.

Julien Frey1, Basile F E Curchod, Rosario Scopelliti, Ivano Tavernelli, Ursula Rothlisberger, Mohammad K Nazeeruddin, Etienne Baranoff.   

Abstract

While phosphorescent cyclometalated iridium(iii) complexes have been widely studied, only correlations between oxidation potential EOX and Hammett constant σ, and between the redox gap (ΔEREDOX = EOX-ERED) and emission or absorption wavelength (λabs, λem) have been reported. We present now a quantitative model based on Hammett parameters that rationalizes the effect of the substituents on the properties of cyclometalated iridium(iii) complexes. This simple model allows predicting the apparent redox potentials as well as the electrochemical gap of homoleptic complexes based on phenylpyridine ligands with good accuracy. In particular, the model accounts for the unequal effect of the substituents on both the HOMO and the LUMO energy levels. Consequently, the model is used to anticipate the emission maxima of the corresponding complexes with improved reliability. We demonstrate in a series of phenylpyridine emitters that electron-donating groups can effectively replace electron-withdrawing substituents on the orthometallated phenyl to induce a blue shift of the emission. This result is in contrast with the common approach that uses fluorine to blue shift the emission maximum. Finally, as a proof of concept, we used electron-donating substituents to design a new fluorine-free complex, referred to as EB343, matching the various properties, namely oxidation and reduction potentials, electrochemical gap and emission profile, of the standard sky-blue emitter FIrPic.

Entities:  

Year:  2013        PMID: 24345847     DOI: 10.1039/c3dt52739e

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  7 in total

1.  Quantum-chemical studies of homoleptic iridium(III) complexes in OLEDs: fac versus mer isomers.

Authors:  Izabela Grzelak; Bartosz Orwat; Ireneusz Kownacki; Marcin Hoffmann
Journal:  J Mol Model       Date:  2019-05-10       Impact factor: 1.810

2.  Bis(arylimidazole) Iridium Picolinate Emitters and Preferential Dipole Orientation in Films.

Authors:  Aron J Huckaba; Alessia Senes; Sadig Aghazada; Azin Babaei; Stefan C J Meskers; Iwan Zimmermann; Pascal Schouwink; Natalia Gasilova; René A J Janssen; Henk J Bolink; Mohammad Khaja Nazeeruddin
Journal:  ACS Omega       Date:  2018-03-06

3.  Blue-to-Green Emitting Neutral Ir(III) Complexes Bearing Pentafluorosulfanyl Groups: A Combined Experimental and Theoretical Study.

Authors:  Amlan K Pal; Adam F Henwood; David B Cordes; Alexandra M Z Slawin; Ifor D W Samuel; Eli Zysman-Colman
Journal:  Inorg Chem       Date:  2017-06-14       Impact factor: 5.165

4.  Crystal structure and Hirshfeld surface analysis of 1,2-bis-(2',6'-diisoprop-oxy-[2,3'-bipyridin]-6-yl)benzene.

Authors:  Ki-Min Park; Suk-Hee Moon; Youngjin Kang
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2018-09-25

5.  Crystal structure of bis-[2-tert-but-oxy-6-fluoro-3-(pyridin-2-yl-κN)pyridin-4-yl-κC (4)](pentane-2,4-dionato-κ(2) O,O')iridium(III).

Authors:  Ki-Min Park; Youngjin Kang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-10-29

6.  Synthesis, Properties, and Light-Emitting Electrochemical Cell (LEEC) Device Fabrication of Cationic Ir(III) Complexes Bearing Electron-Withdrawing Groups on the Cyclometallating Ligands.

Authors:  Amlan K Pal; David B Cordes; Alexandra M Z Slawin; Cristina Momblona; Enrique Ortı; Ifor D W Samuel; Henk J Bolink; Eli Zysman-Colman
Journal:  Inorg Chem       Date:  2016-09-28       Impact factor: 5.165

7.  Excited-State Engineering in Heteroleptic Ionic Iridium(III) Complexes.

Authors:  Filippo Monti; Andrea Baschieri; Letizia Sambri; Nicola Armaroli
Journal:  Acc Chem Res       Date:  2021-02-22       Impact factor: 24.466

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.